Ensituximab
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Chimeric (mouse/human) |
Target | 5AC |
Clinical data | |
ATC code | none |
Identifiers | |
CAS Number | 1092658-06-4 |
ChemSpider | none |
UNII | F988K568V2 |
Chemical and physical data | |
Formula | C6342H9800N1678O1985S46 |
Molar mass | 142.8 kg/mol |
(what is this?) (verify) |
Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.[1]
Ensituximab was developed by Neogenix Oncology, Inc.
References
- ↑ "Statement On A Nonproprietary Name Adopted By The USAN Council: Ensituximab" (PDF). American Medical Association.
This article is issued from Wikipedia - version of the 9/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.